Treats acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. ANDA 72168, held by Hospira. Cytarabine.
As of Nov 16, 2026, ANDA 72168 (Cytarabine), held by Hospira, was first approved by FDA on Aug 31, 1990, with 18 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 1990 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cytarabine20MG/ML · injectable;injection | Cytarabine | Rx |
| Aug 3, 2026 | Supplement 36Labeling · Standard review | Approved | None posted |
| Jun 2, 2020 | Supplement 30Labeling · Standard review | Approved | None posted |
| Jan 15, 2019 | Supplement 29Labeling · Standard review | Approved | None posted |
| Jan 15, 2019 | Supplement 28Labeling · Standard review | Approved | None posted |
| Apr 19, 2004 | Supplement 19Labeling | Approved | None posted |
| May 14, 2001 | Supplement 16Manufacturing | Approved | None posted |
| Aug 8, 2000 | Supplement 14Manufacturing | Approved | None posted |
| May 18, 2000 | Supplement 13Manufacturing | Approved | None posted |
| May 12, 2000 | Supplement 12Manufacturing | Approved | None posted |
| Jun 2, 1997 | Supplement 9Labeling | Approved | None posted |
| Apr 16, 1997 | Supplement 8Manufacturing | Approved | None posted |
| Apr 28, 1995 | Supplement 7Manufacturing | Approved | None posted |
| Sep 23, 1994 | Supplement 5Labeling | Approved | None posted |
| May 23, 1994 | Supplement 6Manufacturing | Approved | None posted |
| Feb 25, 1993 | Supplement 1Manufacturing | Approved | None posted |
| Apr 22, 1991 | Supplement 3Manufacturing | Approved | None posted |
| Apr 22, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Mar 15, 1991 | Supplement 4Manufacturing | Approved | None posted |
| Aug 31, 1990 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters